Suchergebnisse - "Richardson, Caroline J."

PubPharm (16)

1

ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

enthalten in: Molecular cancer therapeutics | 2021

von Munck, J. | Berdini, V. | Bevan, L. | +24

2

1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity

enthalten in: Journal of medicinal chemistry | 2013

von Cano, C. | Saravanan, K. | Bailey, C. | +14

3

1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity

enthalten in: Journal of medicinal chemistry | 2013

von Cano, C. | Saravanan, K. | Bailey, C. | +14

4

Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function

enthalten in: Nature chemical biology | 2012

von Saalau-Bethell, S. | Woodhead, A. | Chessari, G. | +10

5

Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function

enthalten in: Nature chemical biology | 2012

von Saalau-Bethell, S. | Woodhead, A. | Chessari, G. | +10

6

Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K

enthalten in: Molecular cancer therapeutics | 2012

von Munck, J. | Batey, M. | Zhao, Y. | +15

7

DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype

enthalten in: Journal of medicinal chemistry | 2010

von Cano, C. | Barbeau, O. | Bailey, C. | +14

8

AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders

enthalten in: British journal of haematology | 2010

von Dawson, M. | Curry, J. | Barber, K. | +10

9

AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders

enthalten in: British journal of haematology | 2010

von Dawson, M. | Curry, J. | Barber, K. | +10

10

Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase

enthalten in: Journal of medicinal chemistry | 2007

von Hollick, J. | Rigoreau, L. | Cano-Soumillac, C. | +16